Literature DB >> 23639559

Neuroimaging in patients with abnormal blood glucose levels.

G Bathla1, B Policeni2, A Agarwal3.   

Abstract

SUMMARY: Smooth neuronal functioning requires an uninterrupted supply of energy that is provided by glucose under normal physiologic conditions. Significant variations in plasma glucose levels, be it hypoglycemia or hyperglycemia, can present with myriad clinical manifestations and may mimic stroke. At times, the diagnosis is either not apparent or not clinically suspected. Imaging can suggest the diagnosis in unsuspected cases and can help in the assessment of the extent of neuronal damage in known cases, making it vital for the neuroradiologist to be aware of both common and atypical neuroimaging findings in hypoglycemia and hyperglycemia.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23639559      PMCID: PMC7964537          DOI: 10.3174/ajnr.A3486

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  57 in total

1.  Generalized chorea-ballism in acute non ketotic hyperglycemia: findings from diffusion-weighted magnetic resonance imaging.

Authors:  Francesca Massaro; Pasquale Palumbo; Mario Falcini; Gianna Zanfranceschi; Andrea Pratesi
Journal:  Parkinsonism Relat Disord       Date:  2012-04-26       Impact factor: 4.891

2.  Serial diffusion and perfusion-weighted MR in transient hypoglycemia.

Authors:  C Cordonnier; C Oppenheim; C Lamy; J-F Meder; J-L Mas
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

Review 3.  Brain imaging findings in neonatal hypoglycemia: case report and review of 23 cases.

Authors:  Arie L Alkalay; Laura Flores-Sarnat; Harvey B Sarnat; Franklin G Moser; Charles F Simmons
Journal:  Clin Pediatr (Phila)       Date:  2005 Nov-Dec       Impact factor: 1.168

4.  Case report: hypoglycemia and diffusion-weighted imaging.

Authors:  Roxanne Chan; Sami Erbay; Stephen Oljeski; David Thaler; Rafeeque Bhadelia
Journal:  J Comput Assist Tomogr       Date:  2003 May-Jun       Impact factor: 1.826

Review 5.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

Review 6.  Roles of circadian rhythmicity and sleep in human glucose regulation.

Authors:  E Van Cauter; K S Polonsky; A J Scheen
Journal:  Endocr Rev       Date:  1997-10       Impact factor: 19.871

7.  Early diffusion MR imaging findings and short-term outcome in comatose patients with hypoglycemia.

Authors:  K Johkura; Y Nakae; Y Kudo; T N Yoshida; Y Kuroiwa
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

8.  Seizures in hyperglycemic patients.

Authors:  K M Sabitha; A S Girija; K S Vargese
Journal:  J Assoc Physicians India       Date:  2001-07

9.  Ischemic hyperintensities on T1-weighted magnetic resonance imaging of patients with stroke: new insights from susceptibility weighted imaging.

Authors:  Neeraj N Baheti; Ajith Cherian; P R Wattamwar; Chandrasekharan Kesavadas; Bejoy Thomas
Journal:  Neurol India       Date:  2010 Jan-Feb       Impact factor: 2.117

10.  Impact of fasting glycemia and regional cerebral perfusion in diabetic subjects: a study with technetium-99m-ethyl cysteinate dimer single photon emission computed tomography.

Authors:  Francesco Cosentino; Rodolfo Battista; Angelo Scuteri; Francesco De Sensi; Luca De Siati; Carmen Di Russo; Giovanni G Camici; Massimo Volpe
Journal:  Stroke       Date:  2008-10-09       Impact factor: 7.914

View more
  17 in total

1.  Paediatric non-ketotic hyperglycaemic hemichorea-hemiballismus.

Authors:  Cezar Thomas Reyes Suratos; James Albert Edward Lim Benitez; Sheen Corvera Urquiza; Cheryl Anne Lubaton Sacro
Journal:  BMJ Case Rep       Date:  2018-04-05

2.  Unilateral striatal CT and MRI changes secondary to non-ketotic hyperglycaemia.

Authors:  Bushra Johari; Mohammad Hanafiah; Azura Mohamed Mukhari Shahizon; Marymol Koshy
Journal:  BMJ Case Rep       Date:  2014-05-02

3.  Thalamus L-Sign: A Potential Biomarker of Neonatal Partial, Prolonged Hypoxic-Ischemic Brain Injury or Hypoglycemic Encephalopathy?

Authors:  S K Misser; J W Lotz; R van Toorn; N Mchunu; M Archary; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

4.  Diabetic striatopathy in a patient with hemiballism.

Authors:  Anıl Özgür; Kaan Esen; Hakan Kaleağası; Arda Yılmaz; Engin Kara
Journal:  Emerg Radiol       Date:  2015-03-13

5.  Magnetic resonance imaging findings in patients with non-ketotic hyperglycaemia and focal seizures.

Authors:  Sara Rosa Maria De Martino; Francesco Toni; Luca Spinardi; Luigi Cirillo
Journal:  Neuroradiol J       Date:  2020-06-15

6.  Seizures and movement disorders induced by hyperglycemia without ketosis in elderly.

Authors:  Samia Younes; Yousra Cherif; Mouna Aissi; Wafa Alaya; Olfa Berriche; Amel Boughammoura; Mahbouba Frih-Ayed; Baha Zantour; Mohamed Habib Sfar
Journal:  Iran J Neurol       Date:  2014-07-04

Review 7.  Understanding the Epilepsy in POLG Related Disease.

Authors:  Omar Hikmat; Tom Eichele; Charalampos Tzoulis; Laurence A Bindoff
Journal:  Int J Mol Sci       Date:  2017-08-24       Impact factor: 5.923

8.  New-Onset Diabetes Presenting as Monoballism Secondary to a Mixed Hyperglycemic Crisis.

Authors:  Miguel A Garcia-Grimshaw; Amado Jimenez-Ruiz; Alberto Ornelas-Velazquez; Adrian Luna-Armenta; Francisco A Gutierrez-Manjarrez
Journal:  Cureus       Date:  2018-06-26

9.  Importance of Contrast-Enhanced Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging in Various Intracranial Pathologic Conditions.

Authors:  Eun Kyoung Lee; Eun Ja Lee; Sungwon Kim; Yong Seok Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

10.  Unusual Magnetic Resonance Imaging Abnormality in Nonketotic Hyperglycemia - related Epilepsia Partialis Continua.

Authors:  Jui-Ping Tsai; Jau-Jiuan Sheu; Kevin Li-Chun Hsieh
Journal:  Ann Indian Acad Neurol       Date:  2018 Jul-Sep       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.